Department of Orthopaedic Surgery, University of Virginia School of Medicine, Charlottesville, Virginia, U.S.A.
Department of Orthopaedic Surgery, University of Virginia School of Medicine, Charlottesville, Virginia, U.S.A..
Arthroscopy. 2018 May;34(5):1561-1569. doi: 10.1016/j.arthro.2017.11.034. Epub 2018 Feb 3.
To determine the association between glycemic control and infection following knee arthroscopy, and to determine the clinical utility of a threshold HbA1c level.
A national database identified patients who underwent knee arthroscopy from 2007 to 2016. Patients with concomitant open portions, more complex knee procedures, procedures performed for infection and patients with prior septic knee arthritis were excluded. Patients with an HbA1c level checked within 3 months of surgery were compared to control groups of nondiabetics and diabetics undergoing knee arthroscopy without a perioperative HbA1c. The study group was then stratified based on their HbA1c. The incidence of deep infection within 6 months was identified and compared to those in the control groups. A subgroup analysis was performed to investigate any trend in the timing of postoperative infection. A receiver operating characteristic (ROC) analysis was performed to determine and test a threshold value of HbA1c.
13,470 study patients were included, with an overall rate of infection of 0.33%. The rate of infection ranged from 0.25% to 1.03%. The rate of infection in study patients was greater than the nondiabetes control group's (P < .0001) and not significantly different from that in the nonstudy diabetes control (P = .765). The inflection point of the ROC curve corresponded to an HbA1c level of 8.0 mg/dL (P = .006, specificity = 76%, sensitivity = 44%, area under curve [AUC] = 0.619).
The risk of infection following knee arthroscopy increases as the perioperative HbA1c increases. ROC analysis determined that an HbA1c above 8.0 mg/dL could serve as a threshold level; however, the AUC and low sensitivity reflected the poor utility of this test as an independent predictor for infection.
Level III, retrospective comparative study.
确定膝关节镜检查术后血糖控制与感染之间的关系,并确定 HbA1c 阈值水平的临床实用性。
国家数据库确定了 2007 年至 2016 年期间接受膝关节镜检查的患者。排除了同时存在开放性部分、更复杂的膝关节手术、因感染而进行的手术以及有既往脓毒性膝关节炎的患者。将在手术前 3 个月内检查 HbA1c 的患者与非糖尿病患者和未进行围手术期 HbA1c 的糖尿病患者的对照组进行比较。然后根据他们的 HbA1c 将研究组分层。确定并比较 6 个月内深部感染的发生率。进行亚组分析以研究术后感染时间的任何趋势。进行接收者操作特征 (ROC) 分析以确定和测试 HbA1c 的阈值。
共纳入 13470 例研究患者,感染率为 0.33%。感染率范围为 0.25%至 1.03%。研究患者的感染率高于非糖尿病对照组(P<0.0001),与非研究糖尿病对照组无显著差异(P=0.765)。ROC 曲线的拐点对应于 HbA1c 水平 8.0mg/dL(P=0.006,特异性为 76%,敏感性为 44%,曲线下面积 [AUC]为 0.619)。
膝关节镜检查术后感染的风险随着围手术期 HbA1c 的升高而增加。ROC 分析确定 HbA1c 高于 8.0mg/dL 可作为阈值水平;然而,AUC 和低敏感性反映了该测试作为感染的独立预测因子的实用性较差。
III 级,回顾性比较研究。